BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25339024)

  • 1. Relation of serum adiponectin levels and obesity with breast cancer: a Japanese case-control study.
    Minatoya M; Kutomi G; Shima H; Asakura S; Otokozawa S; Ohnishi H; Akasaka H; Miura T; Mori M; Hirata K
    Asian Pac J Cancer Prev; 2014; 15(19):8325-30. PubMed ID: 25339024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of serum isoflavone, insulin and adiponectin levels with breast cancer risk.
    Minatoya M; Kutomi G; Asakura S; Otokozawa S; Sugiyama Y; Ohnishi H; Akasaka H; Miura T; Mori M; Hirata K
    Breast Cancer; 2015 Sep; 22(5):452-61. PubMed ID: 24166746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
    Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
    Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum adiponectin but not leptin at diagnosis as a predictor of breast cancer survival.
    Lee SA; Sung H; Han W; Noh DY; Ahn SH; Kang D
    Asian Pac J Cancer Prev; 2014; 15(15):6137-43. PubMed ID: 25124587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between adiponectin and two different cancers: breast and colon.
    Gulcelik MA; Colakoglu K; Dincer H; Dogan L; Yenidogan E; Gulcelik NE
    Asian Pac J Cancer Prev; 2012; 13(1):395-8. PubMed ID: 22502709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating High-Molecular-Weight (HMW) Adiponectin Level Is Related with Breast Cancer Risk Better than Total Adiponectin: A Case-Control Study.
    Guo MM; Duan XN; Cui SD; Tian FG; Cao XC; Geng CZ; Fan ZM; Wang X; Wang S; Jiang HC; Zhang JG; Jin F; Tang JH; Liang H; Yang ZL; Wang HB; Wang QT; Li GL; Li L; Zhu SG; Zuo WS; Liu LY; Wang L; Ma DD; Liu SC; Xiang YJ; Liu L; Ye CM; Zhou WZ; Wang F; Yu LX; Ma ZB; Yu ZG
    PLoS One; 2015; 10(6):e0129246. PubMed ID: 26070203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum adiponectin levels with breast cancer risk.
    Miyoshi Y; Funahashi T; Kihara S; Taguchi T; Tamaki Y; Matsuzawa Y; Noguchi S
    Clin Cancer Res; 2003 Nov; 9(15):5699-704. PubMed ID: 14654554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of adiposity, lifetime physical activity and serum adiponectin in occurrence of breast cancer among Malaysian women in Klang Valley.
    Shahar S; Salleh RM; Ghazali AR; Koon PB; Mohamud WN
    Asian Pac J Cancer Prev; 2010; 11(1):61-6. PubMed ID: 20593932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
    Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
    Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
    Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
    Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Obesity and the Risk of Breast Cancer among Pre and Postmenopausal Women.
    Gravena AAF; Romeiro Lopes TC; Demitto MO; Borghesan DHP; Dell’ Agnolo CM; Brischiliari SCR; Carvalho MDB; Pelloso SM
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2429-2436. PubMed ID: 30255696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
    Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Rohan TE; Manson JE; Li J; Ho GY; Xue X; Anderson GL; Kaplan RC; Harris TG; Howard BV; Wylie-Rosett J; Burk RD; Strickler HD
    J Natl Cancer Inst; 2009 Jan; 101(1):48-60. PubMed ID: 19116382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin and breast cancer risk.
    Mantzoros C; Petridou E; Dessypris N; Chavelas C; Dalamaga M; Alexe DM; Papadiamantis Y; Markopoulos C; Spanos E; Chrousos G; Trichopoulos D
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1102-7. PubMed ID: 15001594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthropometric measures, plasma adiponectin, and breast cancer risk.
    Tian YF; Chu CH; Wu MH; Chang CL; Yang T; Chou YC; Hsu GC; Yu CP; Yu JC; Sun CA
    Endocr Relat Cancer; 2007 Sep; 14(3):669-77. PubMed ID: 17914097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
    Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
    Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and risk of breast cancer molecular subtypes in Korean women: a case-control study.
    Jeong SH; An Y; Ahn C; Park B; Lee MH; Noh DY; Park SK
    Breast Cancer Res Treat; 2020 Jan; 179(2):459-470. PubMed ID: 31628583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in early breast cancer associated with body mass index, physical functioning, physical activity, and comorbidity: data from a nationwide Danish cohort.
    Guldberg TL; Christensen S; Zachariae R; Jensen AB
    Breast Cancer Res Treat; 2017 Feb; 162(1):159-167. PubMed ID: 28078491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
    Assiri AM; Kamel HF; Hassanien MF
    Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.